Serological Cancer Markers 1992
DOI: 10.1007/978-1-4612-0401-5_13
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Applications of CA 15–3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

1993
1993
2007
2007

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 41 publications
0
3
0
1
Order By: Relevance
“…These are either high molecular weight mucines or are blood group antigens. Apart from in the presence of tumoral diseases, they are also secreted by normal tissues [2,3].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…These are either high molecular weight mucines or are blood group antigens. Apart from in the presence of tumoral diseases, they are also secreted by normal tissues [2,3].…”
Section: Discussionmentioning
confidence: 99%
“…ESWL results in histopathological changes in the tissue, biochemical changes in the serum and urine, and hormonal and hematological changes both in vitro and in vivo [1][2][3][4]. The effect of ESWL on carbohydrate antigens (CA) has not been investigated to date.…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…A sensibilidade varia de acordo com a massa tumoral e o estadiamento clínico, sendo de 88% a 96% na doença disseminada 24 . Na fase inicial, apenas 23% dos casos apresentam aumento deste marcador 25 . Aumento superior a 25% na concentração do CA 15.3 correlaciona-se com a progressão da doença em 80% a 90% dos casos, e a diminuição em sua concentração está associada à regressão em 70% a 80% 3 .…”
Section: Ca 153unclassified